Mairene Llerena-Coto

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing.

Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 24, 2025

Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Journal: Molecular cancer

Published: October 17, 2025

Immuno-Activated, Highly Expressing PD-1 Phenotype in Hepatocellular Carcinoma Is Associated with a Lower Recurrence Rate.

Immuno-Activated, Highly Expressing PD-1 Phenotype in Hepatocellular Carcinoma Is Associated with a Lower Recurrence Rate.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: May 15, 2024

A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth.

A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth.

Journal: Journal of visualized experiments : JoVE

Published: February 19, 2024

Ribosomal protein RPL39L is an efficiency factor in the cotranslational folding of a subset of proteins with alpha helical domains.

Ribosomal protein RPL39L is an efficiency factor in the cotranslational folding of a subset of proteins with alpha helical domains.

Journal: Nucleic acids research

Published: May 24, 2023

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer.

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer.

Journal: NPJ precision oncology

Published: February 23, 2023

Arginine reprograms metabolism in liver cancer via RBM39.

Arginine reprograms metabolism in liver cancer via RBM39.

Journal: Cell

Published: December 09, 2022

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.

Journal: Communications biology

Published: July 05, 2022

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.

Journal: JCO precision oncology

Published: March 09, 2022

The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective.

The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective.

Journal: Frontiers in medicine

Published: March 03, 2022

Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues.

Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues.

Journal: Frontiers in oncology

Published: September 23, 2021

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.

Journal: Communications medicine

Published: September 21, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026